Healthpeak Properties (NYSE:DOC) Releases Quarterly Earnings Results, Beats Estimates By $0.40 EPS

Key Points

• Healthpeak reported $0.45 EPS for the quarter, beating the consensus of $0.05 by $0.40 and updated FY2026 guidance to 1.710–1.750 EPS.
• The company declared a monthly dividend of $0.1017 (record June 15, payable June 26), implying an annualized yield of about 7.4%.
• Shares rose roughly 1.5% to $16.54 after the report; the REIT has a market cap of $11.5B, a P/E of 165.4, and institutional ownership of about 93.6%.

Healthpeak Properties (NYSE:DOC - Get Free Report) announced its quarterly earnings data on Tuesday. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.40, Zacks reports. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. Healthpeak Properties updated its FY 2026 guidance to 1.710-1.750 EPS.

Healthpeak Properties Stock Up 1.5%

Shares of DOC traded up $0.25 during midday trading on Tuesday, reaching $16.54. 7,755,449 shares of the company were exchanged, compared to its average volume of 8,978,304. The stock has a 50-day moving average price of $16.94 and a 200-day moving average price of $17.15. The company has a market cap of $11.50 billion, a price-to-earnings ratio of 165.44, a P/E/G ratio of 2.27 and a beta of 1.00. Healthpeak Properties has a 1-year low of $15.70 and a 1-year high of $19.68. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a yield of 7.4%. Healthpeak Properties's dividend payout ratio (DPR) is 1,220.00%.

Analyst Ratings Changes

Several equities analysts recently issued reports on DOC shares. Wells Fargo & Company reissued a "positive" rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Robert W. Baird cut their price target on shares of Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating on the stock in a research note on Monday, April 6th. Citigroup cut their price target on shares of Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research note on Wednesday, April 1st. Scotiabank raised shares of Healthpeak Properties to a "hold" rating in a research note on Thursday, April 23rd. Finally, UBS Group initiated coverage on shares of Healthpeak Properties in a research note on Monday, April 20th. They set a "neutral" rating and a $17.00 price target on the stock. Five equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $18.04.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds have recently modified their holdings of DOC. State Street Corp boosted its holdings in Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock worth $947,889,000 after acquiring an additional 895,460 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after purchasing an additional 4,776,056 shares during the period. Invesco Ltd. lifted its position in shares of Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust's stock worth $294,244,000 after purchasing an additional 1,648,012 shares in the last quarter. Morgan Stanley lifted its position in shares of Healthpeak Properties by 0.6% during the fourth quarter. Morgan Stanley now owns 12,251,344 shares of the real estate investment trust's stock worth $197,002,000 after purchasing an additional 71,508 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Healthpeak Properties by 4.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 11,107,199 shares of the real estate investment trust's stock valued at $178,604,000 after purchasing an additional 523,818 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.